Table 1.

Summary of five cardiovascular-related studies in COVID-19 patients

Author	Journal / year	Diseases studied	Conclusions	Recommendations
Driggin E et al	JACC 2020	Patient risk assessment: infection and cardiovascular issues	The COVID-19 has substantially increased the difficulty of treating patients with severe emergent CVD	Individualized diagnosis and treatment measures tailored to specific local epidemic situations should be developed
Guo T et al	JAMA Cardiol 2020	Association of underlying CVD and myocardial injury with fatal outcomes in COVID-19	Myocardial injury is associated with cardiac dysfunction, arrhythmias and fatal outcome of COVID-19. The prognosis of patients with underlying CVD but without myocardial injury is relatively favourable.	Aggressive treatment may be considered for patients at high risk of myocardial injury
Zheng YY et al	Nat Rev Cardiol 2020	Underlying CVD	COVID-19 patients with underlying CVD have an adverse prognosis	Particular attention should be given to CV protection during treatment for COVID-19
Madjid M et al	JAMA Cardiol 2020	Underlying CVD and/or cardiac risk factors	COVID-19 is associated with a high inflammatory burden that can induce vascular inflammation, myocarditis, and cardiac arrhythmias.	CV risk factors and conditions should be controlled per evidence-based guidelines
Han Y et al	Circulation AHA 2020	Patient risk assessment of both infection and CV issues	Patient risk assessment of both infection and CV issues. Consider the prevention and control of COVID-19 transmission as the highest priority	Individualized diagnosis and treatment measures tailored to specific local epidemic situations should be developed.

CV = cardiovascular, CVD = cardiovascular diseases